arrow
M

Monali Manohar

Stanford University
H指数:30
被引数:4,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peanut allergy oral immunotherapy drives single-cell multi-omic changes in peanut-reactive T cells associated with sustained unresponsiveness

花生过敏口服免疫疗法驱动与持续无反应性相关的花生反应性T细胞的单细胞多体变化

2025-11-040
OAAI
Drivers of differential antibody breadth in SARS-CoV-2 mRNA vaccination and infection

SARS-CoV-2 mRNA疫苗接种和感染中差异抗体宽度的驱动因素

2025-11-010
PRE
Trends in allergen-reactive CRTH2+ T cells and TARC associated with successful outcomes in a phase 2 cashew oral immunotherapy study

与一个2期腰果口服免疫疗法研究成功结局相关的过敏原反应性CRTH2+ T细胞和TARC的趋势

2025-10-220
OAAI
Shrimp oral immunotherapy outcomes in the phase 2 clinical trial: MOTIF

虾口服免疫疗法在2期临床试验中的结果:MOTIF

2025-07-220
OA
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8+T cell responses post SARS-CoV-2 infection

Spheromers揭示了对辉瑞/BioNTech疫苗的强大T细胞反应和SARS-CoV-2感染后减弱的外周CD8 T细胞反应

IMMUNITY
IF26.3
2023-04-0146
OAAI
HLA-associated outcomes in peanut oral immunotherapy trials identify mechanistic and clinical determinants of therapeutic success
2022-11-184
OAAI
Food-specific immunoglobulin A does not correlate with natural tolerance to peanut or egg allergens
2022-11-1616
OA
CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy
2022-11-0410
OAAI
STAT5B restrains human B-cell differentiation to maintain humoral immune homeostasis
2022-10-0126
PRE
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
2022-07-0116
OAAI
New-onset IgG autoantibodies in hospitalized patients with COVID-19
2021-09-14287
OAAI
Gastrointestinal Eosinophil Responses in a Longitudinal, Randomized Trial of Peanut Oral Immunotherapy
2021-06-0143
OAAI
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome
2020-12-18356
OAAI